Download PDF
CC BY-NC-ND 4.0 · Journal of Fetal Medicine 2014; 01(02): 81-88
DOI: 10.1007/s40556-014-0013-z
Review Article

Treatment and Prevention of Rh Isoimmunization

Krishna Agarwal
1   Department of Obstetrics and Gynecology, Maulana Azad Medical College, 110002, New Delhi, India
,
Anubhuti Rana
1   Department of Obstetrics and Gynecology, Maulana Azad Medical College, 110002, New Delhi, India
,
Anoosha K. Ravi
1   Department of Obstetrics and Gynecology, Maulana Azad Medical College, 110002, New Delhi, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

Rhesus (Rh) isoimmunization is an important clinical entity in India and other developing countries, which is responsible for fetal anemia and hydrops fetalis, and if not treated, it can result in intrauterine fetal demise. Rh isoimmunization is responsible for severe jaundice in neonates, which can be severe enough to cause kernicterus with debilitating consequences, if not treated adequately. It can be prevented with simple measures and treated if recognized in time.

Keywords

Rhesus D antigen - Isoimmunization - Fetomaternal hemorrhage - Prevention of Rh isoimmunization - Middle cerebral artery peak systolic velocity


Publication History

Received: 03 June 2014

Accepted: 16 September 2014

Article published online:
08 May 2023

© 2014. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India